default image

Klinik für Urologie

Rubensstraße 125
12157 Berlin

Phone: 030-13020-2541
Mail: ed.setnaviv@sairahcaz.oiram
With emergency ambulance
Approach

Medical administration

MU Dr. Dr. h.c. Mario Zacharias (Chefarzt)

Information and services of the department

  • Number of inpatient cases: 3.260

Services search (in the department)


Illness Number of cases
Hyperplasia of prostate (N40) 819
Malignant neoplasm of prostate (C61) 308
Other disorders of urinary system - Urinary tract infection site not specified (N39.0) 167
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 155
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) 146
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 112
Calculus of kidney and ureter - Calculus of ureter (N20.1) 112
Unspecified haematuria (R31) 101
Calculus of kidney and ureter - Calculus of kidney (N20.0) 90
Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) 71
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 1.409
Surgical removal or destruction of prostatic tissue through the urethra (5-601.70) 932
Examination of the urethra and the urinary bladder by endoscopy (1-661) 725
(1-931.0) 629
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) 382
Injection or administration of medicines into the urinary bladder (8-132.x) 348
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 319
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 242
Insertion, exchange or removal of a ureteral stent (8-137.13) 236
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 202

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
140 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
94 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
61 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies nur Phase-II-Studien
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision
No. Training in other healing professions Comment
HB03 Physical therapist / physiotherapist (m/f) seit April 2022
HB05 Medical technical radiology assistant (MTRA) (m/f) seit April 2021, seit 2023 neue Bundesgesetzgebung in Umsetzung
HB07 Surgical technical assistant (m/f) ab 2022, neue Bundesgesetzgebung umgesetzt
HB09 Speech therapist (m/f) seit Oktober 2022
HB10 Midwife (m/f) seit Oktober 2021, Studium mit der Universität der Charité Berlin
HB12 Medical technical laboratory assistant (MTLA) (m/f) seit Februar 2023, neue Bundesgesetzgebung umgesetzt
HB15 Anaesthesia technical assistant (m/f) ab 2022, Bundesgesetzgebung umgesetzt
HB16 Dietician (m/f) seit Oktober 2021
HB19 Nursing professionals seit 2020, Pflegefachassistenz seit November 2022, Umsetzung der neuen Ausbildung nach Landesgesetzgebung
HB20 Nursing professional B. Sc. Kooperationspartner für die ASH
HB06 Occupational therapist (m/f) ab 10/2024 in Umsetzung
HB13 Medical technical assistant for functional diagnostics (MTAF) (m/f) Seit 04/2023
HB17 Auxiliary nurse (m/f) Seit 04/2022 nach neuer Gesetzgebung des Landes Berlin Pflegefachassistenz

Frau Saskia Möschl

Patientenfürsprecherin (Psychiatrie

Rubensstraße 125
12157 Berlin

Phone: 030 -13020-2774
Mail: ed.nilreb@2-kva.viv-ftap

Frau Daniela Golz

Patientenfürsprecherin (Somatik

Rubensstraße 125
12157 Berlin

Phone: 030 -13020-8393
Mail: ed.nilreb@1-kva.viv-ftap

Christine Wolter-Paulick

Qualitätsmanagerin

Rubensstraße 125
12157 Berlin

Phone: 030 -13020-2291
Mail: ed.setnaviv@kbw.kva.mq

Dr. J. Danckert

GF Klinikmanagement

Rubensstraße 125
12157 Berlin

Phone: 030 -13010-
Mail: ed.setnaviv@ofni

Dr. Mario Zacharias

Ärztlicher Direktor

Rubensstraße 125
12157 Berlin

Phone: 030 -13020-2541
Mail: ed.setnaviv@sairahcaz.oiram

Dr. Ulrike Zuther

Leitung Vivantes Apotheke Süd

Rubensstraße 125
12157 Berlin

Phone: 030 -13014-2560
Mail: ed.setnaviv@rehtuz.ekirlu